Announcements

Michael J. Murray, Executive Vice President and Chief Operating Officer of D.R. Horton, Inc., filed a Form 4 on November 9, 2026, disclosing a series of transactions in the company's common stock dated November 5 and November 8, 2026.

Paul J. Romanowski, President and CEO of D.R. Horton, Inc., filed a Form 4 on November 9, 2026, reporting the vesting of restricted stock units and a related tax-withholding share surrender on November 8, 2026.

Director Ray Stata filed a Form 4 with the SEC on November 9, 2026, disclosing the sale of 1,317 shares of Analog Devices common stock on November 5, 2026, pursuant to a Rule 10b5-1 trading plan.

D.R. Horton EVP and CFO Bill W. Wheat filed a Form 4 on November 9, 2026, reporting the vesting of restricted stock units and a related tax-withholding share surrender on November 8, 2026.

Daniel Brignardello, Executive Vice President of EVERTEC, Inc., filed a Form 4 on November 9, 2026, disclosing a disposition of 1,880 shares of common stock on November 5, 2026, related to the vesting of restricted stock units.

Orchestra BioMed Holdings, Inc. filed a Form 8-K on November 9, 2026, disclosing the entry into an underwriting agreement and the closing of an underwritten public offering of common stock that generated approximately $86.3 million in gross proceeds.

Andrew Lawrence Taylor, Chief Financial Officer of Orchestra BioMed Holdings, Inc., filed a Form 4 on November 9, 2026, disclosing the purchase of 1,000 shares of common stock at $5.00 per share in an underwritten public offering.